Navigation Links


Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA

4/1/2015
SEATTLE , April 1, 2015  Adaptive Biotechnologies today announced publication of a study in The Lancet Oncology showing that analysis of circulating tumor DNA (ctDNA) using the company's next-generation sequencing-based minimal residual disease (MRD) detection and quantification technology (available clinically as the clonoSEQ™ MRD test) accurately identifies pat... [Comments]

Biosearch and Co-Diagnostics Sign Cooperative Primers Agreement

4/1/2015
Salt Lake City, UT (PRWEB) April 01, 2015 Biosearch Technologies and Co-Diagnostics announced today an agreement allowing Biosearch to make, use, market and sell Co-Diagnostics’ CoPrimers™ technology to research institutions. The agreement also licenses CoPrimers™ technology to Biosearch for its own research and development. CoPrimers’™ unique patent-pending design greatly reduces the occu... [Comments]

Shimadzu Nexera UC Recognized at Pittcon 2015 with Editors’ Gold Award

4/1/2015
(PRWEB) April 01, 2015 Shimadzu Corporation announced that its fully automated supercritical fluidic chromatography-based Nexera Unified Chromatography system (Nexera UC) received the Pittcon Editors’ Gold award at the 2015 Pittsburg Conference on Analytical Chemistry and Applied Spectroscopy (Pittcon) held in New Orleans, LA between March 8th and 12th. The Pittcon Editors’ Awards recog... [Comments]

Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners

4/1/2015
MANCHESTER, N.H. , April 1, 2015 Emerson Ecologics is excited to announce its first annual conference, IGNITE: The Business of Better Medicine . The conference will provide integrative healthcare practitioners with the necessary business knowledge to develop a thriving and fulfilling practice. Scheduled for November 13-15, 2015 at the Omni La Costa Resort and Spa, the conf... [Comments]

Park Systems Awarded the New Economy Magazine “Best Analytic Instrumentation Company 2014”

4/1/2015
Santa Clara, CA (PRWEB) April 01, 2015 Park Systems, world-leader in Atomic Force Microscopes (AFM) was selected to receive the prestigious “Best Analytic Instrumentation Company Award 2014” by The New Economy Magazine.    Park NX10 is the premium research-grade True Non-Contact AFM, featuring industry-leading Z-servo speed, XY and Z scanner linearity, closed-loop dete... [Comments]

VLP Therapeutics Enters Collaboration with Institute of Tropical Medicine, Nagasaki University

4/1/2015
GAITHERSBURG, Md. , April 1, 2015  VLP Therapeutics, LLC. ("VLP"), a Gaithersburg -based biotechnology company focusing on the research and development of therapeutic and preventative vaccines and next generation antibody agents based upon a novel and proprietary vaccine technology, today announced that it has entered into a research collaboration with the Institut... [Comments]

ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101

4/1/2015
FREMONT, Calif. , April 1, 2015  ValGenesis Inc., the market leader in enterprise Validation Lifecycle Management Software solutions, announced today that it has completed its Service Organization Controls 2 (SOC 2) examination under AT Section 101, Attest Engagements (AICPA, Professional Standards) for the period of January 1 st  2014  through December 31 st 2... [Comments]

Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech

4/1/2015
BALTIMORE , Apr. 1, 2015 Goldman Small Cap Research, a stock market research firm specializing on the small cap and microcap sectors, announced today that it has issued a new article on PharmaCyte Biotech, Inc. (OTCQB – PMCB), a publicly traded clinical stage biotechnology company focused on developing and preparing treatments for cancer and diabetes. To view the sponsor... [Comments]

Portage's Biohaven Announces Agreement with inVentiv Health

4/1/2015
TORONTO , April 1, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that Biohaven Pharmaceutical Holding Company Limited (Biohaven), which Portage holds 54% equity, has entered into an agreement with inVentiv Health for the operational execution of Biohaven's first clinical trial with their lead compound (BHV... [Comments]

EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology

4/1/2015
ROCKLAND, Mass. , April 1, 2015  EMD Serono, the U.S. biopharmaceuticals subsidiary of Merck KGaA, Darmstadt, Germany , announced today the appointment of Frederick E. Munschauer to Vice President of Medical Affairs, Neurology and Immunology. In this capacity, he will lead the medical affairs activities for clinical, commercial and business development projects and co... [Comments]

[next]
(Date:3/20/2015)... , Mar. 20, 2015 Research and Markets ... addition of the "India Sensors Market Forecast ... The sensor market is projected to ... Consumer electronics, automotive, industrial and healthcare ... in the country. In addition, adoption of MEMS ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... wallet is one of the products featured in 2015 ... 20th at 11:00 PM EST on the DIY Network. ... Las Vegas , site of the ...
(Date:3/19/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... this week on Washington DC,s Fox ... segment "The Next Great Thing", host Laura Evans ... and ,a really big breakthrough in mobile payment.,  ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... In 2005, the overall cost of patients' time spent on cancer ... to a new study in the January 3 issue of the ... for the 11 cancers studied and for different phases of cancer ... the direct medical costs of cancer care, but few have attempted ...
... the January issue of the journal Cell Metabolism, published by ... the formation of a poorly understood type of muscle. Moreover, ... IIX fibers were able to run farther and at higher ... ultimately lead to novel drugs designed to change the composition ...
... insect cells ?not in eggs, where flu vaccines currently available ... effective as conventional vaccines in protecting people against the flu, ... the Journal of the American Medical Association. , Removing eggs ... health officials seeking to protect the population from seasonal flu ...
Cached Biology News:Study calculates patient time costs associated with cancer care 2Study calculates patient time costs associated with cancer care 3'Marathon mice' elucidate little-known muscle type 2'Marathon mice' elucidate little-known muscle type 3Bypassing eggs, flu vaccine grown in insect cells shows promise 2Bypassing eggs, flu vaccine grown in insect cells shows promise 3
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100*...
Recombinant Equine TNF-alpha/TNFSF1A, CF...
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
Biology Products:
(Date:4/1/2015)... April 1, 2015  ValGenesis Inc., the market leader ... that it has completed its Service Organization Controls 2 ... (AICPA, Professional Standards) for the period of January 1 ... ... The SOC 2 examination is ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... addition of the "Blood Screening Market by ... Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product ... - Forecasts to 2019 " report to ... is expected to reach $2.55 billion by 2019 ...
(Date:4/1/2015)... NEW YORK , April 1, 2015 ... biopharmaceutical company advancing protein biologic therapies and oncology ... the Company,s 2014 achievements and a strategic update ... progress the Company has made in the areas ... its MuGard programs, the FDA clearance of the ...
(Date:4/1/2015)... The concept of “spot reducing” areas is a huge ... Fasciology, Ashley Black, says that even the idea of being ... to wait for the whole fat system to reduce is ... cooling procedures, the only well known way to spot ... a highly invasive procedure.” It is common knowledge that weight ...
Breaking Biology Technology:ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 3Global Blood Screening (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting) Market 2015-2019 2Global Blood Screening (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting) Market 2015-2019 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 5PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 6Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 2Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 3
... The medical imaging company SyntheticMR AB, ... order for their magnetic resonance imaging software from Umeå ... be used in clinical practice to monitor the treatment ... SyMRI Diagnostics, includes tools to automatically estimate a measure ...
... Verenium Corporation (Nasdaq: VRNM ), a leading ... of high-performance enzymes, today announced James Levine, President and ... Mr. Levine will present at the upcoming ... September 12, 2011.  The presentation is expected to begin ...
... Switzerland, September 1, 2011 Study Assessing ... in mid 2012 Kuros Biosurgery AG, a ... and bioactive-biomaterial combination products for trauma, wound and spinal ... a Phase IIb clinical trial designed to investigate KUR-211 ...
Cached Biology Technology:Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation 2Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation 3Verenium to Present at Upcoming Conferences 2Verenium to Present at Upcoming Conferences 3Kuros Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers 2Kuros Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers 3